These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25749266)

  • 41. Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination.
    Barzilay EJ; O'Brien KL; Kwok YS; Hoekstra RM; Zell ER; Reid R; Santosham M; Whitney CG; Feikin DR
    Vaccine; 2006 Feb; 24(7):904-13. PubMed ID: 16203059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?
    Musher DM; Sampath R; Rodriguez-Barradas MC
    Clin Infect Dis; 2011 Mar; 52(5):633-40. PubMed ID: 21292668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A 10-valent conjugate vaccine for some countries.
    Prescrire Int; 2011 Jan; 20(112):8. PubMed ID: 21462783
    [No Abstract]   [Full Text] [Related]  

  • 44. Pneumococcal vaccination for Indian children.
    Levine OS; Cherian T
    Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301
    [No Abstract]   [Full Text] [Related]  

  • 45. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.
    Miiro G; Kayhty H; Watera C; Tolmie H; Whitworth JA; Gilks CF; French N
    J Infect Dis; 2005 Nov; 192(10):1801-5. PubMed ID: 16235180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults.
    Metlay JP; Fishman NO; Joffe M; Edelstein PH
    Vaccine; 2006 Jan; 24(4):468-75. PubMed ID: 16125826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 13-valent pneumococcal conjugate vaccine.
    Prescrire Int; 2011 Jan; 20(112):5-7, 9. PubMed ID: 21462782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reconsidering Guidelines on the Use of Pneumococcal Vaccines in Adults 65 Years or Older.
    Hochman M; Cohen PA
    JAMA Intern Med; 2015 Dec; 175(12):1895-6. PubMed ID: 26502317
    [No Abstract]   [Full Text] [Related]  

  • 49. Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.
    Holmlund E; Nohynek H; Quiambao B; Ollgren J; Käyhty H
    Vaccine; 2011 Jun; 29(28):4565-75. PubMed ID: 21550374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
    Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
    Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee.
    Nace DA; Archbald-Pannone LR; Ashraf MS; Drinka PJ; Frentzel E; Gaur S; Mahajan D; Mehr DR; Mercer WC; Sloane PD; Jump RL;
    J Am Med Dir Assoc; 2017 Feb; 18(2):99-104. PubMed ID: 28126142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumococcal conjugate vaccine--relevance for developing countries.
    Mulholland K
    Indian Pediatr; 2001 May; 38(5):453-60. PubMed ID: 11359971
    [No Abstract]   [Full Text] [Related]  

  • 53. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New pneumococcal vaccine].
    Gaudelus J
    Bull Acad Natl Med; 2003; 187(8):1477-86; discussion 1486-8. PubMed ID: 15146579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: a Belgian consensus report.
    Peetermans WE; Van de Vyver N; Van Laethem Y; Van Damme P; Thiry N; Trefois P; Geerts P; Schetgen M; Peleman R; Swennen B; Verhaegen J
    Acta Clin Belg; 2005; 60(6):329-37. PubMed ID: 16502593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
    Whitney CG
    Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What are the latest recommendations for pneumococcal vaccines?
    Fabel PH; Horton EC; Shealy K
    JAAPA; 2016 Apr; 29(4):13-4. PubMed ID: 27023652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Conjugate pneumococcal vaccines in pediatric population: up to date].
    Hausdorff W; Lepetic A; De Antonio R
    Rev Chilena Infectol; 2014 Dec; 31(6):763-4. PubMed ID: 25679940
    [No Abstract]   [Full Text] [Related]  

  • 60. Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants.
    Knuf M; Pankow-Culot H; Grunert D; Rapp M; Panzer F; Köllges R; Fanic A; Habib A; Borys D; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2012 Jan; 31(1):e31-6. PubMed ID: 21909049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.